DICER1 Mutation in Recurrent Ovarian Sertoli-Leydig Cell Tumor: A Case Report.

J Pediatr Adolesc Gynecol

Department of Obstetrics and Gynaecology, Queen's University, Kingston, Ontario, Canada; Division of Gynaecologic Oncology, Queen's University, Kingston, Ontario, Canada.

Published: April 2023

Background: DICER1 mutation has been linked to development of Sertoli-Leydig cell tumor and cystic nephroma, among other neoplasms.

Case: We present a unique case of recurrent ovarian Sertoli-Leydig cell tumor in a pediatric patient with a known DICER1 mutation and history of cystic nephroma. She underwent surgical staging and adjuvant chemotherapy, and her recurrences have been treated with chemotherapy, whole-abdomen radiation therapy, and further surgical debulking.

Conclusion: This report adds to the small body of evidence about this rare but unexpectedly highly aggressive tumor, especially in the recurrent setting, and reminds the reader of the importance of cancer diagnosis in this population.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpag.2022.11.003DOI Listing

Publication Analysis

Top Keywords

dicer1 mutation
12
sertoli-leydig cell
12
cell tumor
12
recurrent ovarian
8
ovarian sertoli-leydig
8
cystic nephroma
8
mutation recurrent
4
tumor
4
tumor case
4
case report
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!